Correction to: Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trial

Anne Christin Rahn^{1

2}, Lisa Wenzel^{3

4}, Andrea Icks⁵, Alexander Stahmann⁶, Jutta Scheiderbauer⁷, Kristina Grentzenberg³, Markus Vomhof⁵, Joseph Montalbo⁵, Tim Friede⁸, Christoph Heesen^{3

9}, Sascha Köpke⁴

Affiliations

¹ Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. anne.christin.rahn@uni-oldenburg.de.
² Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany. anne.christin.rahn@uni-oldenburg.de.
³ Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁴ Institute of Nursing Science, University Hospital Cologne and Faculty of Medicine, University of Cologne, Cologne, Germany.
⁵ Institute for Health Services Research and Health Economics, Centre for Health and Society, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
⁶ MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.
⁷ Stiftung für Selbstbestimmung und Selbstvertretung von MS-Betroffenen, Trier, Germany.
⁸ Department of Medical Statistics, University Medical, Göttingen, Germany.
⁹ Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Published Erratum

Anne Christin Rahn et al. Trials. 2021.

. 2021 Mar 8;22(1):196.

doi: 10.1186/s13063-021-05152-5.

¹ Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. anne.christin.rahn@uni-oldenburg.de.
² Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany. anne.christin.rahn@uni-oldenburg.de.
³ Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁴ Institute of Nursing Science, University Hospital Cologne and Faculty of Medicine, University of Cologne, Cologne, Germany.
⁵ Institute for Health Services Research and Health Economics, Centre for Health and Society, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
⁶ MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.
⁷ Stiftung für Selbstbestimmung und Selbstvertretung von MS-Betroffenen, Trier, Germany.
⁸ Department of Medical Statistics, University Medical, Göttingen, Germany.
⁹ Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Erratum for

Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trial.
Rahn AC, Wenzel L, Icks A, Stahmann A, Scheiderbauer J, Grentzenberg K, Vomhof M, Montalbo J, Friede T, Heesen C, Köpke S. Rahn AC, et al. Trials. 2021 Feb 14;22(1):139. doi: 10.1186/s13063-021-05059-1. Trials. 2021. PMID: 33583424 Free PMC article.

1. Rahn AC, et al. Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial. Trials. 2021;21:139. doi: 10.1186/s13063-021-05059-1. - DOI - PMC - PubMed